Synergio Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Synergio General Information
Description
Developer of a data-driven computational platform designed to leverage a deep understanding of plants to accelerate health and sustainability worldwide. The company's platform uses a patented microtargeting technology that synergizes nature's microtargeting mechanisms to develop healthy ingredients, enabling enterprises to deliver the desired positive effects without adverse side effects.
Contact Information
Website
www.synergio.comCorporate Office
- Biohouse Labs, Manrav Building
- Level 1, Hadassah Ein Kerem
- Jerusalem 9112001
- Israel
Corporate Office
- Biohouse Labs, Manrav Building
- Level 1, Hadassah Ein Kerem
- Jerusalem 9112001
- Israel
Synergio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 03-Feb-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 25-Aug-2021 | Cancelled | Generating Revenue | |||
| 4. Later Stage VC | 20-Jul-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 31-Dec-2019 | Completed | Generating Revenue | |||
| 2. Grant | 21-Oct-2019 | $500K | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Oct-2015 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Synergio Patents
Synergio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026210475-A2 | Antimicrobial natural compositions containing cinnamon | Pending | 30-Mar-2025 | ||
| JP-2025504635-A | Antibacterial composition | Pending | 27-Jan-2022 | ||
| AU-2022438363-A1 | Antimicrobial compositions | Inactive | 27-Jan-2022 | ||
| EP-4469037-A1 | Antimicrobial compositions | Pending | 27-Jan-2022 | ||
| EP-4469037-A4 | Antimicrobial compositions | Pending | 27-Jan-2022 | A61K8/498 |
Synergio Signals
Synergio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Symrise | Corporation | Minority | ||
| Connecticut Innovations | Venture Capital | Minority | ||
| Kli Capital | Venture Capital | Minority | ||
| Safer Made | Venture Capital | Minority | ||
| VentureClash | Other |
Synergio FAQs
-
When was Synergio founded?
Synergio was founded in 2007.
-
Where is Synergio headquartered?
Synergio is headquartered in Jerusalem, Israel.
-
What is the size of Synergio?
Synergio has 13 total employees.
-
What industry is Synergio in?
Synergio’s primary industry is Other Healthcare Technology Systems.
-
Is Synergio a private or public company?
Synergio is a Private company.
-
What is Synergio’s current revenue?
The current revenue for Synergio is .
-
How much funding has Synergio raised over time?
Synergio has raised $25M.
-
Who are Synergio’s investors?
Symrise, Connecticut Innovations, Kli Capital, Safer Made, and VentureClash are 5 of 6 investors who have invested in Synergio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process